The OpenPET geometry is our new idea to visualize a physically opened space between two detector rings. In this paper, we developed the first small prototype to show a proof-of-concept of OpenPET imaging. Two detector rings of 110 mm diameter and 42 mm axial length were placed with a gap of 42 mm. The basic imaging performance was confirmed through phantom studies; the open imaging was realized at the cost of slight loss of axial resolution and 24% loss of sensitivity. For a proof-of-concept of PET image-guided radiation therapy, we carried out the in-beam tests with (11)C radioactive beam irradiation in the heavy ion medical accelerator in Chiba to visualize in situ distribution of primary particles stopped in a phantom. We showed that PET images corresponding to dose distribution were obtained. For an initial proof-of-concept of real-time multimodal imaging, we measured a tumor-inoculated mouse with (18)F-FDG, and an optical image of the mouse body surface was taken during the PET measurement by inserting a digital camera in the ring gap. We confirmed that the tumor in the gap was clearly visualized. The result also showed the extension effect of an axial field-of-view (FOV); a large axial FOV of 126 mm was obtained with the detectors that originally covered only an 84 mm axial FOV. In conclusion, our initial imaging studies showed promising performance of the OpenPET.
We develop an OpenPET system which can provide an accessible open space to the patient during PET scanning. Our first-generation OpenPET geometry which we called dual-ring OpenPET consisted of two separated detector rings and it could extend its axial field of view (FOV) therefore enabling imaging the gap region in addition to the in-ring region. However, applications such as dose verification by in-beam PET measurement during particle therapy and real-time tumor tracking by PET require sensitivity focused onto the gap rather than on the wide FOV. In this paper, we propose a second-generation OpenPET geometry, single-ring OpenPET, which can provide an accessible and observable open space with higher sensitivity and a reduced number of detectors than the earlier one. The proposed geometry has a cylinder shape cut at a slant angle, in which the shape of each cut end becomes an ellipse. We provided a theoretical analysis for sensitivity of the proposed geometry, compared with the dual-ring OpenPET and a geometry where the conventional PET was positioned at a slant angle against the patient bed to form an accessible open space, which we called a slant PET. The central sensitivity depends on the solid angle of these geometries. As a result, we found that the single-ring OpenPET has a sensitivity 1.2 times higher than the dual-ring OpenPET and 1.3 times higher than the slant PET when designed for a 600 mm bed width with 300 mm accessible open space and about 200 detector blocks, each with a front area of 2500 mm². In addition, numerical simulation was carried out to show the imaging property of the proposed geometry realized with the ellipsoidal rings and these results indicate that the depth-of-interaction detector can provide uniform resolution even when the detectors are arranged in an ellipsoidal ring.
Peritoneal dissemination is a common cause of death from gastrointestinal cancers and is difficult to treat using current therapeutic options, particularly late-phase disease. Here, we investigated the feasibility of integrated therapy using 64Cu-intraperitoneal radioimmunotherapy (ipRIT), alone or in combination with positron emission tomography (PET)-guided surgery using a theranostic agent (64Cu-labeled anti-epidermal growth factor receptor antibody cetuximab) to treat early- and late-phase peritoneal dissemination in mouse models. In this study, we utilized the OpenPET system, which has open space for conducting surgery while monitoring objects at high resolution in real time, as a novel approach to make PET-guided surgery feasible. 64Cu-ipRIT with cetuximab inhibited tumor growth and prolonged survival with little toxicity in mice with early-phase peritoneal dissemination of small lesions. For late-phase peritoneal dissemination, a combination of 64Cu-ipRIT for down-staging and subsequent OpenPET-guided surgery for resecting large tumor masses effectively prolonged survival. OpenPET clearly detected tumors (≥3 mm in size) behind other organs in the peritoneal cavity and was useful for confirming the presence or absence of residual tumors during an operation. These findings suggest that integrated 64Cu therapy can serve as a novel treatment strategy for peritoneal dissemination.
The single-ring OpenPET (SROP), for which the detector arrangement has a cylinder shape cut by two parallel planes at a slant angle to form an open space, is our original proposal for in-beam PET. In this study, we developed a small prototype of an axial-shift type SROP (AS-SROP) with a novel transformable architecture for a proof-of-concept. In the AS-SROP, detectors originally forming a cylindrical PET are axially shifted little by little. We designed the small AS-SROP prototype for 4-layer depth-of-interaction detectors arranged in a ring diameter of 250 mm. The prototype had two modes: open and closed. The open mode formed the SROP with the open space of 139 mm and the closed mode formed a conventional cylindrical PET. The detectors were simultaneously moved by a rotation handle allowing them to be transformed between the two modes. We evaluated the basic performance of the developed prototype and carried out in-beam imaging tests in the HIMAC using (11)C radioactive beam irradiation. As a result, we found the open mode enabled in-beam PET imaging at a slight cost of imaging performance; the spatial resolution and sensitivity were 2.6 mm and 5.1% for the open mode and 2.1 mm and 7.3% for the closed mode. We concluded that the AS-SROP can minimize the decrease of resolution and sensitivity, for example, by transforming into the closed mode immediately after the irradiation while maintaining the open space only for the in-beam PET measurement.
We proposed a concept of whole gamma imaging (WGI) that utilizes all detectable gamma rays for imaging. An additional detector ring, which is used as the scatterer, is inserted in the field-of-view of a PET ring so that single gamma rays can be detected by the Compton imaging method. In particular, for the non-pure positron emitters which emit an additional gamma ray almost at the same time, triple gamma imaging will be enabled; localization on each line-of-response (LOR) is possible by using the Compton cone of the additional gamma ray. We developed a prototype to show a proof of the WGI concept. The diameters of scatterer ring and PET ring were set as 20 cm and 66 cm, respectively. For Compton imaging of the 662-keV gamma ray from a 137Cs point source, spatial resolution obtained by the list-mode OSEM algorithm was 4.4 mm FWHM at the 8 cm off-center position and 13.1 mm FWHM at the center position. For PET imaging of a 22Na point source, spatial resolution was about 2 mm FWHM at all positions. For the triple gamma imaging, 5.7 mm FWHM (center) and 4.8 mm FWHM (8 cm off-center) were obtained for the 22Na point source just by plotting the intersecting points between each LOR and each Compton cone of the 1275-keV gamma ray. No image reconstruction was applied. Scandium-44 was produced as a practical candidate of the non-pure positron emitters, and 6.6 mm FWHM (center) and 5.8 mm FWHM (8 cm off-center) were obtained in the same manner. This direct imaging approach which neither requires time-consuming event integration nor iterative image reconstruction may allow in vivo real-time tracking of a tiny amount of activity. Our initial results showed the feasibility of the WGI concept, which is a novel combination of PET and Compton imaging.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.